Cushman & Wakefield (CWK)
(Delayed Data from NYSE)
$12.68 USD
+0.62 (5.14%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $12.69 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.68 USD
+0.62 (5.14%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $12.69 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
Key Factors to Impact Prologis (PLD) This Earnings Season
by Zacks Equity Research
While Prologis' (PLD) Q2 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, high supply and elevated interest expenses might partly limit the growth tempo.
Is the Options Market Predicting a Spike in Cushman & Wakefield (CWK) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cushman & Wakefield (CWK) stock based on the movements in the options market lately.
Redfin (RDFN) Moves 5.3% Higher: Will This Strength Last?
by Zacks Equity Research
Redfin (RDFN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
What's in Store for Gladstone Commercial (GOOD) in Q1 Earnings?
by Zacks Equity Research
Gladstone Commercial's (GOOD) Q1 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, though high supply might partly limit the growth tempo
Vornado (VNO) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Healthy demand for Vornado's (VNO) premium office assets is likely to have benefited its Q1 performance. However, higher interest expenses are anticipated to have hurt it.
Cushman & Wakefield (CWK) Reports Break-Even Earnings for Q1
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 100% and 2.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Kimco (KIM) This Earnings Season?
by Zacks Equity Research
While a healthy retail real estate market and focus on developing mixed-use assets are likely to have aided Kimco's (KIM) Q1 earnings, higher interest expenses may have hurt it.
Key Factors to Impact Boston Properties' (BXP) Q1 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q1 earnings. However, high interest expenses remain a concern.
TPG RE Finance Trust (TRTX) Reports Next Week: What Awaits?
by Zacks Equity Research
TPG RE Finance Trust (TRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cushman & Wakefield (CWK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Cushman & Wakefield (CWK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cushman & Wakefield (CWK) Could Beat Earnings Estimates Again
by Zacks Equity Research
Cushman & Wakefield (CWK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cushman & Wakefield (CWK) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 15.38% and 2.17%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CBRE Group (CBRE) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CBRE Group's (CBRE) Q4 results reflect the benefits from the expansion of its resilient business in recent years despite the challenging macro environment.
Vornado (VNO) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Although Vornado (VNO) has premium office assets in key markets, its Q4 performance is likely to be affected by the choppy office real estate market environment and high interest expenses.
Key Factors to Impact Boston Properties' (BXP) Q4 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q4 earnings. However, higher interest expenses might have hurt the company.
Key Factors to Impact Prologis (PLD) This Earnings Season
by Zacks Equity Research
Prologis' (PLD) Q4 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, though high supply might partly limit the growth tempo.
Cushman & Wakefield (CWK) Tops Q3 Earnings Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 5% and 2.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Key Factors to Impact Boston Properties' (BXP) Q3 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q3 earnings. However, higher interest expenses might have hurt it.
CBRE Group (CBRE) Q3 Earnings Beat on Resilient Business Growth
by Zacks Equity Research
CBRE Group's (CBRE) Q3 results reflect the benefits of diversification and the expansion of its resilient business in recent years despite the challenging macro environment.
Vornado (VNO) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Healthy demand for Vornado's (VNO) premium office assets is likely to have benefited its Q3 earnings. However, higher interest expenses are anticipated to have hurt it.
Earnings Preview: Newmark Group (NMRK) Q3 Earnings Expected to Decline
by Zacks Equity Research
Newmark Group (NMRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Cushman & Wakefield (CWK) Q3 Earnings Expected to Decline
by Zacks Equity Research
Cushman & Wakefield (CWK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Factors to Impact Prologis (PLD) This Earnings Season
by Zacks Equity Research
Prologis' (PLD) Q3 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, though high supply might partly limit the growth tempo.
New Strong Sell Stocks for October 6th
by Zacks Equity Research
DIOD, CWK and D have been added to the Zacks Rank #5 (Strong Sell) List on October 6, 2023.
Company News for Sep 15, 2023
by Zacks Equity Research
Companies in The News Are: HPQ, BRK.B, SMTC, MRNA, CWK